Abstract
Cryptococcosis is an infection that may be lethal in patients with nephrotic syndrome (NS). However, there is relatively limited epidemiological and clinical data about cryptococcosis in NS patients. We performed a pooled analysis to systemically summarize the epidemiology, risk factors, clinical and laboratory characteristics, treatments and outcomes of cryptococcosis in NS patients. Using data pooled from our hospital and studies identified via searches of three literature databases, 17 cases were identified for inclusion in this analysis. The prevalence of cryptococcosis in NS was 0.3%, with a higher rate in more recent years. Most patients were Asian (94%) and from upper-middle to high-income countries (76%). The median time interval from NS diagnosis to cryptococcosis diagnosis among the cryptococcosis patients was 16 months, and 46% of the identified cryptococcal infections were diagnosed within the first year of NS diagnosis. Cutaneous cryptococcosis was frequently diagnosed among the included patients (35%), 58% received an erroneous diagnosis and inappropriate treatment, 90% of whom had a cryptococcal infection mistaken for a bacterial infection. The mortality rate was 35%. Standard therapeutic strategies should be emphasized for both antifungal treatment and renal disease control. Further studies conducted in various medical centers are warranted to confirm our conclusions.
Similar content being viewed by others
References
Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionov E, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol. 2015;78:16–48. doi:10.1016/j.fgb.2015.02.009.
Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33(5):690–9. doi:10.1086/322597.
Phillips P, Galanis E, MacDougall L, Chong MY, Balshaw R, Cook VJ, et al. Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia. Clin Infect Dis. 2015;60(9):1368–76. doi:10.1093/cid/civ041.
Du L, Yang Y, Gu J, Chen J, Liao W, Zhu Y. Systemic review of published reports on primary cutaneous cryptococcosis in immunocompetent patients. Mycopathologia. 2015;180(1–2):19–25. doi:10.1007/s11046-015-9880-7.
Chen M, Al-Hatmi AM, Chen Y, Ying Y, Fang W, Xu J, et al. Cryptococcosis and tuberculosis co-infection in mainland China. Emerg Microbes Infect. 2016;5(9):e98. doi:10.1038/emi.2016.95.
Fang W, Chen M, Liu J, Hagen F, Ms A, Al H, et al. Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review. Emerg Microbes Infect. 2016;5(9):e95. doi:10.1038/emi.2016.93.
Yang YL, Chen M, Gu JL, Zhu FY, Xu XG, Zhang C, et al. Cryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published cases. Int J Infect Dis. 2014;26:154–61. doi:10.1016/j.ijid.2014.05.028.
Spies FS, de Oliveira MB, Krug MS, Severo CB, Severo LC, Vainstein MH. Cryptococcosis in patients living with hepatitis C and B viruses. Mycopathologia. 2015;179(3–4):307–12. doi:10.1007/s11046-014-9843-4.
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525–30. doi:10.1097/QAD.0b013e328322ffac.
Idnurm A, Lin X. Rising to the challenge of multiple Cryptococcus species and the diseases they cause. Fungal Genet Biol. 2015;78:1–6. doi:10.1016/j.fgb.2015.05.002.
Yuchong C, Fubin C, Jianghan C, Fenglian W, Nan X, Minghui Y, et al. Cryptococcosis in China (1985–2010): review of cases from Chinese database. Mycopathologia. 2012;173(5–6):329–35. doi:10.1007/s11046-011-9471-1.
Barragan NC, Sorvillo F, Kuo T. Cryptococcosis-related deaths and associated medical conditions in the United States, 2000-2010. Mycoses. 2014;57(12):741–6. doi:10.1111/myc.12238.
Sahin SZ, Akalin H, Ersoy A, Yildiz A, Ocakoglu G, Cetinoglu ED, et al. Invasive fungal infections in renal transplant recipients: epidemiology and risk factors. Mycopathologia. 2015;180(1–2):43–50. doi:10.1007/s11046-015-9875-4.
Tan H, Xu Y, Lan XM, Wu YG, Zhou CJ, Yang XC. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome. Mycopathologia. 2015;179(5–6):447–52. doi:10.1007/s11046-014-9856-z.
Ladapo TA, Esezobor CI, Lesi FE. Pediatric kidney diseases in an African country: prevalence, spectrum and outcome. Saudi J Kidney Dis Transpl. 2014;25(5):1110–6.
Sharpstone P, Ogg C, Cameron JS. Nephrotic syndrome due to primary renal disease in adults: I. Survey of incidence in South-east England. BMJ. 1969;2(5656):533–5.
Wu LC, Sun PL, Chang YT. Extensive deep dermatophytosis cause by Trichophyton rubrum in a patient with liver cirrhosis and chronic renal failure. Mycopathologia. 2013;176(5–6):457–62. doi:10.1007/s11046-013-9696-2.
Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008;336(7654):1185–9. doi:10.1136/bmj.39576.709711.80.
Mirdha BR, Sarkar T, Banerjee U, Sethi S, Dan G, Xess I. Concurrent cryptococcal meningitis and falciparum malaria in a child with nephrotic syndrome. Indian Pediatr. 1998;35(4):360–3.
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59. doi:10.1001/jama.2013.168118.
Qadir F, Manzoor K, Ahmed E. Disseminated cryptococcosis in a patient with nephrotic syndrome. Indian J Crit Care Med. 2006;24(2):141–3.
Ogami N, Horino T, Arii K, Takao T, Hashimoto K, Seike M, et al. Primary cutaneous cryptococcosis in a patient with minimal change nephrotic syndrome. Nephrol Dial Transplant. 2005;20(11):2578–9.
Ramos L, López C, Gómez C, Mathurín S, Mateo A. Case report. Cutaneous cryptococcosis in a patient with systemic erythematous lupus. Mycoses. 2001;44(9–10):419–21.
Li S, Arai J, Matsuki S, Asano S, Nishikawa T. A case of nephrotic syndrome associated with cryptococcal meningitis. Nihon Naika Gakkai zasshi J Jpn Soc Intern Med. 1970;59(7):623–7.
Prasun Giri P, Pal P, Rudra Gouda B, Sinha R. Disseminated cryptococcosis in a patient with nephrotic syndrome. Arch Pediatr Infect Dis. 2014;. doi:10.5812/pedinfect.8932.
Nagotkar L, Shanbag P, Mauskar A, Zaki S, Kumar C. Fulminant intracranial hypertension due to cryptococcal meningitis in a child with nephrotic syndrome. Indian J Crit Care Med. 2011;15(3):176–8.
Nakayama M, Hori K, Ishida I, Masutani K, Katafuchi R. A case of necrotizing glomerulonephritis presenting with nephrotic syndrome associated with pulmonary cryptococcosis. Clin Exper Nephrol. 2005;9(1):74–8.
Liu Y, Qunpeng H, Shutian X, Honglang X. Fatal primary cutaneous cryptococcosis: case report and review of published literature. Ir J Med Sci. 2015. doi:10.1007/s11845-015-1346-x.
Lin Z, Yan G, He Y, Zhang G, He W. A case of cutaneous cryptococcosis. J Clin Dermatol. 2004;33(1):25.
Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30(1):47–54. doi:10.1086/313603.
Yuanjie Z, Jianghan C, Nan X, Xiaojun W, Hai W, Wanqing L, et al. Cryptococcal meningitis in immunocompetent children. Mycoses. 2012;55(2):168–71. doi:10.1111/j.1439-0507.2011.02063.x.
Kohno S, Kakeya H, Izumikawa K, Miyazaki T, Yamamoto Y, Yanagihara K, et al. Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan. J Infect Chemother. 2015;21(1):23–30. doi:10.1016/j.jiac.2014.08.025.
Feehally J, Kendell NP, Swift PG, Walls J. High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child. 1985;60(11):1018–20.
Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, et al. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant. 2009;24(8):2406–10. doi:10.1093/ndt/gfp091.
Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50(3):291–322. doi:10.1086/649858.
Acknowledgements
We are thankful for the funds provided by the 973 Program (2013CB531601 and 2013CB531606), Major National R&D Projects of the National Health Department (2014ZX09J14106-02A), National Natural Science Foundation of China (Grant Numbers 81201269, 31270180); and Shanghai Science and Technology Committee (Grant Numbers 14DZ2272900 and 14495800500).
Author Contributions
WL, MC and WP were involved in study concept and design. WF, NH, and YL collected the data. JL and YL checked the data. WF and MC were involved in analysis and interpretation of data. WF drafted the manuscript. All authors contributed to the writing of the final manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declared that they have no conflicts of interest.
Additional information
Wenjie Fang, Nan Hong, Yingfang Li and Jia Liu have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fang, W., Hong, N., Li, Y. et al. Cryptococcosis in Patients with Nephrotic Syndrome: A Pooled Analysis of Cases. Mycopathologia 182, 517–525 (2017). https://doi.org/10.1007/s11046-016-0101-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-016-0101-9